OFFICIAL PUBLICATION OF

by its subsidiary APPco

APP2018

What’s different about biosimilars?

04/05/2018

Dr Paul Cornes oncologist talks biosimilars at APP2018

AJP host Miranda talks to the highly knowledgeable and engaging UK oncologist, Dr Paul Cornes, about biosimilars: what they are, and key learnings from his international experience for the retail pharmacy environment in Australia.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

What’s different about biosimilars?

Previous Disappointment for King, Friends of Science in Medicine

Next Where can pharmacy lead you?

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Disappointment for King, Friends of Science in Medicine

Next Where can pharmacy lead you?

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.